Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
12.36
-2.66 (-17.71%)
At close: Nov 16, 2026
BOM:531015 Market Cap
BOM:531015 has a market cap or net worth of 179.02 million as of November 17, 2026. It is the 48,042nd most valuable company in the world and the 4,817th biggest in India. Its market cap has increased by 17.87% in one year.
Market Cap
179.02M
Enterprise Value
173.74M
Revenue
132.58M
Global Rank
Country Rank
#4,817 India
PE Ratio
48.49
ChartMarket Cap Chart
Since April 15, 2008, BOM:531015's market cap has increased from 32.40M to 179.02M, an increase of 452.55%. That is a compound annual growth rate of 9.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 179.02M | 36.96% |
| Dec 31, 2025 | 130.71M | 38.30% |
| Dec 31, 2024 | 94.51M | 357.87% |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Auro Laboratories | 1.46B |
| Panchsheel Organics | 1.40B |
| Krebs Biochemicals & Industries | 1.27B |
| Tyche Industries | 1.07B |
| Vasundhara Rasayans | 388.69M |
| Alfavision Overseas (India) | 332.91M |
| Crestchem | 297.75M |
| Bacil Pharma | 241.13M |